News & Events
10/23/2011Meet Sovicell at AAPS in Washington DC at joint booth with ADMEcell
10/17/2011Sovicell will present a poster on “TRANSIL High Sensitivity Binding Assay:
9/20/2011Sovicell will be attending Agilent Technologies’ Automation User Group Meeting in San Francisco, California, which is being held from September 20th to 22nd.
9/19/2011Sovicell will be attending the 2nd World Conference on Physico-Chemical Methods in Drug Discovery and Development in Zadar, Croatia, which is being held from September 19th to 22nd.
News & Events
News
Below is a listing of the latest news releases from Sovicell. Interviews and other media inquiries should be arranged by contacting Andrea Berentzik +49 341 520 44 0.
E-mail us.
Sunday, October 23, 2011
Meet Sovicell at AAPS in Washington DC at joint booth with ADMEcellMonday, October 17, 2011
Sovicell will present a poster on “TRANSIL High Sensitivity Binding Assay: A novel tool for assessing plasma binding of hardly soluble and sticky drugs” at the 17th North American Regional ISSX’s 9th Meeting in Atlanta
Tuesday, September 20, 2011
Sovicell will be attending Agilent Technologies’ Automation User Group Meeting in San Francisco, California, which is being held from September 20th to 22nd. Listen to our talk on “Automation of TRANSIL kits for brain tissue binding, plasma binding and liver microsomal binding assays on Agilent’s Bravo liquid handler outperforms traditional methods in preclinical research in terms of speed, cost-effectiveness and reproducibility”.
Monday, September 19, 2011
Sovicell will be attending the 2nd World Conference on Physico-Chemical Methods in Drug Discovery and Development in Zadar, Croatia, which is being held from September 19th to 22nd.Listen to our talk on “TRANSIL High Sensitivity Binding Assay: A novel tool for assessing plasma binding of hardly soluble and sticky drugs” and come to our poster to see our poster on work with GlaxoSmithKline entitled “Brain Tissue Binding of Drugs: evaluation and validation of solid supported porcine brain membrane vesicles (TRANSIL) as a novel high -throughput method”.
Tuesday, June 07, 2011
Sovicell presents talk on “Brain Tissue Binding of Drugs: evaluation and validation of solid supported porcine brain membrane vesicles (TRANSIL) as a novel high -throughput method” at SMi’s ADMET conference in LondonSaturday, April 02, 2011
GlaxoSmithKline publishes validation study of TRANSIL assay for brain tissue binding in Drug Metabolism and Disposition 39:312-321Wednesday, March 30, 2011
Dr. Boriss leads round table discussion on “challenges and opportunities in drug safety prediction“ at the 4th annual BioPharma ASIA convention 2011 in SingaporeWednesday, March 30, 2011
Sovicell presents talk on “Rectifying the potential liabilities of neurotoxicity in early stages of the discovery process” at the 4th annual BioPharma ASIA convention 2011 in SingaporeWednesday, March 23, 2011
Sovicell presents talk on “Brain Tissue Binding of Drugs: Evaluation of Solid Supported Porcine Brain Membrane Vesicles (TRANSIL) as Novel High-Throughput Method” at the BioSoft meeting in BeijingThursday, January 27, 2011
Sovicell presents talk on “Brain Tissue Binding of Drugs: Evaluation of Solid Supported Porcine Brain Membrane Vesicles (TRANSIL) as Novel High-Throughput Method” at the Predictive Human Toxicity/ADME-Tox 2011Tuesday, November 16, 2010
Meet Sovicell at AAPS in New Orleans at joint booth with ADMEcellSaturday, October 23, 2010
Sovicell presents talk on “Predicting neurotoxicity by early assessment of the free concentration of drug in brain” at the 8th International Drug Discovery Science and Technology meeting in BeijingWednesday, July 07, 2010
Sovicell presents talk on “Targeting Drugs for the Brain: Innovative high-throughput method for early prediction of brain availability” at SMi’s ADMET conference in LondonFriday, April 09, 2010
Sovicell presents joint poster with Apredica (Cyprotex) on “Brain Tissue Binding: The Influence of Albumin and Brain Lipids” at the ISSX’s 9th international meeting in IstanbulFriday, April 09, 2010
Sovicell presents joint poster with Apredica (Cyprotex) on “Brain Tissue Binding: The Influence of Albumin and Brain Lipids” at the ISSX’s 9th international meeting in IstanbulThursday, January 28, 2010
Sovicell presents talk on “Predicting neurotoxicity by early assessment of the free concentration of drug in brain” at the Predictive Human Toxicity/ADME-Tox 2010Sunday, October 11, 2009
Meet Sovicell at AAPS in Los Angeles at joint booth with ADMEcellSunday, April 26, 2009
Sovicell presents a poster on their method for predicting the extent of brain penetrationTRANSIL Brain Absorption: An in vitro model for predicting CNS penetration. Presentation at the 15th annual SBS meeting held in Lille.
Download the PDF to read more.
Monday, March 16, 2009
Sovicell presents a talk on optimizing CNS penetration of drugsPresentation of applications for Sovicells in vitro assay for CNS absorption at the SMI conference on "High Throughput Screening for Biological Systems" in London.
Download the PDF to read more.
Sunday, February 08, 2009
Sovicell presents a new method for predicting brain availability at the LogP meetingPresentation of validation data for the TRANSIL Brain Absorption kit for predicting the brain free fraction and the brain-to-plasma distribution at the LogP2009 meeting in Zürich.
Download the PDF to read more.
Thursday, January 22, 2009
Sovicell presents a talk on plasma protein bindingPresentation of pre-clinical applications of the TRANSIL High Protein Binding Assay for plasma protein binding of small molecules and peptides at the predictive human toxicity/ADME-Tox meeting in Brussels.
Download the PDF to read more.
Thursday, February 28, 2008
Nimbus changes name to Sovicell and launches new websiteDownload the PDF to read more.
Wednesday, February 20, 2008
Sovicell announces winner of the iPod raffleCongratulations to the winner of the iPod raffle held at the ADME-Tox Europe meeting in Stockholm! His name is Dr. Markus Probst.
Friday, January 25, 2008
Presentation of first validation data for the TRANSIL blood-to-brain absorption kit at the predictive human toxicity/ADME-Tox meeting in BrusselsThe TRANSIL blood-to-brain absorption kit can be used both to assess the ability of compounds to permeate the blood brain barrier and to predict the equilibrium distribution of compounds between blood and brain. Using a structurally rather diverse test set of drugs it is shown that the test kit’s predictions correlate strongly with in vivo data.
Saturday, September 01, 2007
Release of TRANSIL Blood-to-Brain absorption kitNimbus Biotechnology brings the first ready-to-use assay kit for analyzing drug candidates ability to cross the blood brain barrier to the market.
